King Signs On To Develop Pain Therapeutics’ Abuse-Resistant Oxycodone
The companies intend to file an NDA for the abuse-resistant oxycodone product Remoxy in 2007; King will fund Phase III.
The companies intend to file an NDA for the abuse-resistant oxycodone product Remoxy in 2007; King will fund Phase III.